Global Banking News-December 18, 2018-Mylan NV unveils Mesalamine Delayed-Release Tablets USP in 1.2 g for management of ulcerative colitis in US patients
Enormous efforts have been made to find an effective therapy for IBD although current drugs including sulfasalazine, mesalamine, and corticosteroids taken alone or in combination contribute to decelerating disease progression [3].